Vylibra
Product Images NDC 53002-1777

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Vylibra (NDC 53002-1777). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530021777)

VyLibra Tablets 28-Day, 1 mg, oral tablets packaged for a 28-day regimen by RPK Pharmaceuticals, Inc. The label includes directions for use: take one tablet daily. It has spaces for patient name, date dispensed, clinic name, and prescription details. The label includes NDC numbers for different packaging configurations and storage instructions.*

FDA Label Image

Norgestimate-fig1 (Norgestimate Fig1)

An instructional diagram showing a hand peeling a day label strip to place on a weekly pill pack for VyLibra tablets. The pack displays four rows labeled Week 1 to Week 4, each containing days of the week (Sunday to Saturday) for daily medication tracking. Dosage strength 0.250 mg/0.035 mg and active ingredients (Norgestimate and Ethinyl Estradiol) are listed on the pack. Color coding indicates dark blue pills for weeks 1 to 3 and green pills for week 4.*

FDA Label Image

Norgestimate-fig2 (Norgestimate Fig2)

VyLibra oral contraceptive tablet pack showing a 28-day dosing schedule with pills arranged in four rows labeled Week 1 to Week 4. The pack includes dark blue tablets for the first three weeks and green tablets in the fourth week. The package indicates the active ingredients as norgestimate and ethinyl estradiol with strengths of 0.250 mg/0.035 mg. The day of week is marked across the top from Sunday to Saturday.*

FDA Label Image

Fig3 (Norgestimate Fig3)

An instructional diagram illustrating contraception effectiveness ranked by pregnancies per 100 women in one year. It categorizes methods from fewer pregnancies (implants, injections, intrauterine devices, sterilization) to more pregnancies (no birth control). Intermediate categories include birth control pills, skin patch, vaginal ring, condoms, diaphragm, no sex during fertile days, spermicide, and withdrawal.*

FDA Label Image

Norgestimate-fig4 (Norgestimate Fig4)

An instructional diagram showing how to apply the day-of-week label on a VyLibra tablet blister pack. It highlights the placement of a peel-and-place label over the days of the week at the top, with instructions to pick the correct day label. It includes an image of a hand peeling the label and arrows pointing to various colored areas on the blister pack.*

FDA Label Image

Norgestimate-fig5 (Norgestimate Fig5)

VyLibra 0.25 mg/0.035 mg tablet blister pack by RPK Pharmaceuticals, Inc. The pack shows a 28-day dosing schedule with days of the week labeled from Sunday to Saturday. Tablet colors include dark blue, dark blue, dark blue, and green, indicated with arrows on the left side. The strength of the tablets is 0.250 mg norgestimate and 0.035 mg ethinyl estradiol.*

FDA Label Image

Chemical Structure (Norgestimate Str)

Chemical structure diagram showing two active ingredients, Norgestimate and Ethinyl Estradiol, commonly found in contraceptive medications. Each structure is labeled accordingly with molecular configurations depicted by standard chemical bonds and rings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.